Results 281 to 290 of about 149,286 (348)
Current Status of Research on Losartan in Tumour Therapy
ABSTRACT Losartan, a widely prescribed antihypertensive agent, has attracted growing interest as a potential adjuvant in cancer therapy due to its affordability, established safety profile and pleiotropic effects. Emerging preclinical evidence demonstrates that losartan can effectively modulate the tumour microenvironment (TME) by inhibiting ...
Han Wang, Shuang Yuan, Hongjing Wang
wiley +1 more source
Primary cilium and TULP3-dependent ciliary targeting of ACE2 in SARS-CoV-2 tropism. [PDF]
Du YH +12 more
europepmc +1 more source
Background The COVID‐19 pandemic has led to a variety of long‐term complications, with COVID‐19‐induced idiopathic pulmonary fibrosis (IPF) becoming a major concern. However, the underlying mechanisms, effective therapeutic strategies, and long‐term prognosis of COVID‐19‐related pulmonary fibrosis remain unclear.
Xin Zhang +8 more
wiley +1 more source
Pyrrolopyrimidine derivatives as dual COX-2/ACE2 inhibitors: design, synthesis, and anti-inflammatory evaluation. [PDF]
Afifi H +8 more
europepmc +1 more source
Introduction In approximately 15% of cases undergoing surgery for acute appendicitis (AA), normal findings are observed in the histological examination of the appendix. Neurogenic appendicopathy (NA) is clinically indistinguishable from AA and is relatively less known.
Yavuz Yilmaz +4 more
wiley +1 more source
Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2
J. Huo +32 more
semanticscholar +1 more source
Natural Fatty Acids as Dual ACE2-Inflammatory Modulators: Integrated Computational Framework for Pandemic Preparedness. [PDF]
Lituma-González WD +4 more
europepmc +1 more source
Coronavirus Disease 2019 (COVID-19) Binding Mechanism with Human ACE2: A Computational Approach
Megha Lone, Baliram Lone
openalex +1 more source
Droplet-based single-cell pairing for high-throughput interaction mapping of antigen-receptor combinations. [PDF]
Nan L +8 more
europepmc +1 more source

